New frontiers of near-infrared science and technology
Location: United States, California, Palo Alto
Total raised: $2M
Investors 2
| Date | Name | Website |
| - | MBC BioLab... | mbcbiolabs... |
| - | StartX | startx.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 22.08.2014 | Seed | $2M | - |
Mentions in press and media 4
| Date | Title | Description |
| 19.08.2014 | Nirmidas Biotech Receives $2M | Palo Alto, CA, Nirmidas Biotech, Inc., a diagnostic research technology company, is announcing that it has raised $2 million in seed round funding. >> Click here for more funding data on Nirmidas Biotech >> To export Nirmida... |
| 18.08.2014 | Nirmidas Biotech raises $2M in seed round for fluorescent dye meant for diagnostics | The science comes from the lab of Dr. Hongjie Dai, a chemistry chair at Stanford, who has published extensively about the technology. The technology’s platform is made up of “an ultra-thin, film-like fluorescence enhancing plasmonic gold co... |
| 18.08.2014 | Nirmidas Biotech Raises $2M in Seed Funding | Nirmidas Biotech, Inc., a Palo Alto, CA-based diagnostic research technology company, raised $2m in seed round funding. Backers included a prominent venture capital firm, a life science angel investor, and the Stanford-StartX Fund. The comp... |
| - | Nirmidas Biotech raises $2M in seed round for fluorescent dye meant for diagnostics | Stanford University spinout Nirmidas Biotech has raised $2 million in seed funding to commercialize its fluorescence technology that enhances 100-fold a researcher’s ability to detect disease biomarkers, said the company’s R&D director ... |